Genpact (NYSE:G) is scheduled to be releasing its earnings data after the market closes on Monday, February 12th. Analysts expect Genpact to post earnings of $0.42 per share for the quarter.

Shares of Genpact (G) opened at $31.95 on Friday. The firm has a market capitalization of $6,071.18, a P/E ratio of 23.15, a P/E/G ratio of 1.95 and a beta of 0.57. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.65 and a current ratio of 1.65. Genpact has a fifty-two week low of $23.34 and a fifty-two week high of $34.79.

In other Genpact news, insider Private Ltd Gic sold 1,499,806 shares of Genpact stock in a transaction on Monday, November 20th. The stock was sold at an average price of $30.26, for a total value of $45,384,129.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Mohit Thukral sold 25,000 shares of Genpact stock in a transaction on Tuesday, November 28th. The shares were sold at an average price of $32.25, for a total value of $806,250.00. Following the completion of the transaction, the insider now directly owns 85,305 shares of the company’s stock, valued at $2,751,086.25. The disclosure for this sale can be found here. Insiders sold a total of 1,660,470 shares of company stock valued at $50,598,982 over the last ninety days. Insiders own 1.41% of the company’s stock.

An institutional investor recently raised its position in Genpact stock. The Manufacturers Life Insurance Company lifted its holdings in shares of Genpact Limited (NYSE:G) by 7.5% in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 6,508 shares of the business services provider’s stock after buying an additional 455 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Genpact were worth $181,000 as of its most recent filing with the SEC. 91.99% of the stock is currently owned by institutional investors and hedge funds.

Several research firms recently weighed in on G. Zacks Investment Research cut Genpact from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th. Robert W. Baird reissued a “buy” rating and set a $38.00 price target on shares of Genpact in a report on Friday, November 10th. Finally, Cantor Fitzgerald reissued a “buy” rating and set a $36.00 price target on shares of Genpact in a report on Wednesday, November 8th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $33.38.

WARNING: This piece was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at

Genpact Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Earnings History for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with's FREE daily email newsletter.